Production and Characterization of a High-Affinity Nanobody Against Human Endoglin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Production and Characterization of a High-Affinity Nanobody Against Human Endoglin

Published:2008-10 Issue:5 Volume:27 Page:353-360
ISSN:1554-0014
Container-title:Hybridoma
language:en
Short-container-title:Hybridoma

Author:

Ahmadvand Davoud¹,Rasaee Mohammad J.¹²,Rahbarizadeh Fatemeh²,Mohammadi Mohammad³

Affiliation:

1. Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

2. Department of Medical Biotechnology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

3. Department of Biology, Faculty of Sciences, Shahid Chamran University, Ahvaz, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Immunology,Immunology and Allergy

Link

http://www.liebertpub.com/doi/pdf/10.1089/hyb.2008.0014

Reference38 articles.

1. Engineered antibody fragments and the rise of single domains

2. Immunology and immunotherapy of human cancer: present concepts and clinical developments

3. Immunotherapy: past, present and future

4. Naturally occurring antibodies devoid of light chains

5. Nanobodies as novel agents for cancer therapy

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region;Frontiers in Immunology;2022-04-19

2. Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates;International Immunopharmacology;2022-04

3. Isolation and characterization of a novel nanobody for detection of GRP78 expressing cancer cells;Biotechnology and Applied Biochemistry;2020-05-19

4. Phage Display, Peptide Production and Biological Assessment of Key Sequence of TGF-β1;International Journal of Peptide Research and Therapeutics;2018-10-09

5. The Development of Single Domain Antibodies for Diagnostic and Therapeutic Applications;Antibody Engineering;2018-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3